Skip to main content
Have a personal or library account? Click to login
The Characteristics of Amiodarone-induced Thyrotoxicosis in a Moderate Iodine Deficit Area Cover

The Characteristics of Amiodarone-induced Thyrotoxicosis in a Moderate Iodine Deficit Area

Acta Marisiensis - Seria Medica
Volume 59 (2013): Issue 4 (August 2013)
By: ,   and    
Open Access
|Mar 2014
References

References

  1. 1. Fuks AG, Vaisman M, Buescu. Thyroid dysfunction and cardiological management in patients receiving amiodarone. Arquivos Brasileiros de Cardiologia. 2004;82(6):528-532.
    Search in Google Scholar
  2. 2. Siddoway LA. Amiodarone: guidelines for use and monitoring. American family physician. 2003;68(11):2189-96.
    Search in Google Scholar
  3. 3. Podrid PJ. Amiodarone reevaluation of an old drug. Ann. Intern. Med. 1995;122:689-700.
    Open DOISearch in Google Scholar
  4. 4. Beddows S, Page S, Taylor A, et al. Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes. Biochem. Pharmacol. 1989;38:4397-4403.
    Search in Google Scholar
  5. 5. Basaria S, Cooper D. Amiodarone and the thyroid. Am. J. Med. 2005;118:706-714.
    Open DOISearch in Google Scholar
  6. 6. Padmanabhan H. Amiodarone and thyroid disfunction. South Med. J. A. 2010;103(9):922-930.
    Search in Google Scholar
  7. 7. Trip M, Wiersinga W, Plomp T. Incidence, predictability and pathogenesis of amiodarone - induced thyrotoxicosis and hypothyroidism. Am. J. Med. 1991;91:507-511.
    Open DOISearch in Google Scholar
  8. 8. Hofman A, Nawara C, Ofl uoglu S, et al. Incidence and predictability of amiodaroneinduced thyrotoxicosis and hypothyroidism. Wien Klin Wochenschr. 2008;120(15-16):493-8.
    Open DOISearch in Google Scholar
  9. 9. Martino E, Aghini-Lombardi F, Mariotti S, et al. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm Res. 1987;26:158.
    Open DOISearch in Google Scholar
  10. 10. Martino E, Bartalena L, Bogazzi F, et al. The effects of amiodarone on the thyroid. Endocr. Rev. 2001;22:240-254.
    Search in Google Scholar
  11. 11. Bogazzi F, Martino E, Dell Unto E et al. Thyroid color fl ow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced tyrotoxicosis. J Endocrinol Invest. 2003;26(7):635-640.
    Open DOISearch in Google Scholar
  12. 12. Bogazzi F, Bartalena L, Tomisi L et al. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive tyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J Clin Endocrinol Metab. 2007;92:556-562.
    Open DOISearch in Google Scholar
  13. 13. Piga M, Serra A, Boi F et al. Amiodarone- induced thyrotoxicosis. A review. Minerva Endocrinol. 2008;33(3):213-228.
    Search in Google Scholar
  14. 14. Goldschlager N, Epstein AE, Naccarelli GV, et al. A practical guide for clinicians who treat patients with amiodarone. Heart Rhythm. 2007;4(9):1250-1259.
    Open DOISearch in Google Scholar
  15. 15. Franklyn JA. Amiodarone and thyroid hormone action. Clin. Endocinol. 1985;22:257.
    Search in Google Scholar
  16. 16. Gopalan M. Thyroid dysfunction induced by amiodarone therapy. Updated: Jul 2, 2009. Workup http://emedicine.medscape.com/article/129033-workup#a0723.
    Search in Google Scholar
  17. 17. Sidhu J, Jenkins D. Men are at increased risk of amiodarone-induced thyrotoxicosis in the UK. QJM. 2003;12:949-950.
    Open DOISearch in Google Scholar
  18. 18. Aleksic Z, Aleksic A. Incidence of amiodarone-induced thyroid disfunction and predictive factors for theier occurrence. Med Pregl. 2011;64(11-12): 533-538.
    Open DOISearch in Google Scholar
  19. 19. Liang YL, Huang SM, Peng SL, et al. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter. Ann Pharmacother. 2009;43(1):134-8.
    Open DOISearch in Google Scholar
  20. 20. Tomisti L, Dell’Unto E, Brogioni S, et al. Amiodarone induced thyrotoxicosis in patients with multinodular goiter: type 1 or type 2 AIT? Endocr Abst. 2010;22:765.
    Search in Google Scholar
  21. 21. Davis AB, Orlander PR. Goiter, Toxic Nodular. Updated: Apr 26, 2010. Available from: http://emedicine.medscape.com/article/120497-overview.
    Search in Google Scholar
  22. 22. Bogazzi F, Bartalena L, Dell’Unto E, et al. Proportion of type 1 and type 2 Amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clin Endocrinol. 2007;67:533-537.
    Open DOISearch in Google Scholar
  23. 23. Zosin I, Balas M. Amiodarone induced thyroid disfunction in an iodine replete area: epidemiological and clinical data. Polish Jurnal Endoc. 2012;63(1):2-9.
    Search in Google Scholar
  24. 24. Binz K, Burger A, Vallotton MB. Amiodarone and thyroid function: clinical implications. Schweiz Med Wochenschr. 1998;128:1051-1058.
    Search in Google Scholar
  25. 25. Fiorini A. Monitoring thyroid function status in elderly patients on amiodarone. Malta Med J. 2006;18-24.
    Search in Google Scholar
  26. 26. Kun I, Szántó Z, Balázs J, et al. Detection of Iodine Defi ciency Disorders (Goiter and Hypothyroidism) in School-Children Living in Endemic Mountainous Regions, After the Implementation of Universal Salt Iodization. Hot Topics in Endocrine and Endocrine-Related Diseases, Dr. Monica Fedele (Ed.), ISBN: 978-953-51-1080-4, InTech, DOI: 10.5772/54188.
    Open DOISearch in Google Scholar
  27. 27. Simescu M, Dumitriu L, Kun I, et al. Urinary Iodine Levels in Schoolchildren and Pregnant Women After the Legislative Changes in the Salt Iodization. Acta Endocrinologica New series. 2006;2(1):33-44.
    Open DOISearch in Google Scholar
  28. 28. Toma A, Sava M, Delia C, et al. Universal Salt Iodization Effects on Endemic Goiter in Arges County, Romania. Acta Endocrinologica (Bucharest), New series. 2005;1(2):167-180.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/amma-2013-0045 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 194 - 197
Published on: Mar 7, 2014
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
amiodarone,
hyperthyroidism,
risk factors,
screening and monitoring
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2014 Cota Ancuța-Elena, Căpraru Oana-Maria, Pașcanu Ionela, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons License.

Volume 59 (2013): Issue 4 (August 2013)
Previous article
Next article